Universe Pharmaceuticals Inc (UPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2017 | 12-2006 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | 498,110 | 0 | 443,550 |
| Depreciation Amortization | N/A | N/A | 235,340 | 0 | 188,480 |
| Other Working Capital | N/A | N/A | 1,307,090 | 0 | -1,208,570 |
| Other Operating Activity | 0 | 0 | 174,700 | 0 | 106,070 |
| Operating Cash Flow | $N/A | $N/A | $2,215,240 | $0 | $-470,470 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -44,130 | 0 | -33,880 |
| Net Acquisitions | N/A | N/A | 19,400 | 0 | 0 |
| Other Investing Activity | 0 | 0 | 244,430 | 0 | 3,839,290 |
| Investing Cash Flow | $N/A | $N/A | $219,700 | $0 | $3,805,410 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | N/A | -261,370 | 0 | -274,690 |
| Other Financing Activity | 0 | 0 | -1,641,940 | 0 | -3,148,030 |
| Financing Cash Flow | $N/A | $N/A | $-1,903,310 | $0 | $-3,422,720 |
| Beginning Cash Position | N/A | N/A | 1,130,140 | 0 | 1,054,700 |
| End Cash Position | N/A | N/A | 1,661,780 | 0 | 966,910 |
| Net Cash Flow | $N/A | $N/A | $531,630 | $0 | $-87,780 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | 2,215,240 | 0 | -470,470 |
| Free Cash Flow | 0 | 0 | 2,215,240 | 0 | -470,470 |